A One-Year Prospective Cohort Study of SARS-CoV-2 Infection and Sociodemographic Factors in Thailand

Authors

  • Chakkaphan Runcharoen Faculty of Medical Technology, Huachiew Chalermprakiet University, Samut Prakan, Thailand. E-mail: chakkaphanrun@gmail.com
  • Insee Sensorn Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. E-mail: insee.sen@mahidol.edu
  • Nuttakant Nontawong Department of Medicine, Prachathipat Hospital, Pathum Thani, Thailand. E-mail: nuttakantnontawong@gmail.com
  • Suwannee Surattanasophon Saraburi Regional Hospital, Saraburi, Thailand. E-mail: patellarknee@yahoo.com
  • Thitiya Boonprakob Prachatipat Hospital, Pathum Thani, Thailand. E-mail: thitiyana1965@gmail.com
  • Onura Hemtong Prachatipat Hospital, Pathum Thani, Thailand. E-mail: onura.hemtong@gmail.com
  • Suchada Chowplijit Vichaivej International Hospital (Samut Sakhon), Samut Sakhon, Thailand. E-mail: suchada.chowplijit@hotmail.com
  • Vachara Chuapaknam Vichaivej International Hospital (Samut Sakhon), Samut Sakhon, Thailand. Email: shodan034@yahoo.com
  • Wasun Chantratita Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. E-mail: wasun.cha@mahidol.ac.th

Keywords:

COVID-19, Prospective cohort study, SARS-CoV-2 Infection, Epidemiology, Sociodemographic factors

Abstract

Objective: COVID-19 was declared a global health emergency in January 2020 and a pandemic in March 2020. Although its clinical features and risk factors have been widely studied, most research has relied on retrospective or cross-sectional data, limiting insight into asymptomatic or mildly symptomatic cases. This study aimed to assess the occurrence of SARS-CoV-2 infection and its association with sociodemographic factors in a Thai population.

Method: A one-year prospective cohort study was conducted from October 2021 to November 2022 at Prachatipat Hospital, Pathum Thani (N = 202), and Vichaivej International Hospital (Samut Sakhon), Samut Sakhon (N = 212). Adults aged 18–65 years who were asymptomatic at baseline were enrolled and completed self-administered questionnaires at five time points. Sociodemographic, clinical, and vaccination data were analyzed for associations with infection. Results: The cumulative incidence of SARS-CoV-2 infection was 47% at Prachatipat Hospital and 40% at Vichaivej International Hospital (Samut Sakhon). Reinfections occurred in 5.3% and 17.9% of participants, respectively, with no relapses reported. Genomic surveillance identified Delta and Omicron as the predominant variants during the study period. Common symptoms included cough, sore throat, fever, runny nose, and fatigue. Higher infection rates were observed among healthcare workers and individuals with specific sociodemographic profiles.

Conclusion: These findings provide important insights into infection patterns and risk factors across diverse Thai populations and may support more targeted public health strategies.

References

Jindahra, P., Wongboonsin, K. & Wongboonsin, P. Demographic and initial outbreak patterns of COVID-19 in Thailand. J Popul Res (Canberra) 39, 567-88 (2022). DOI: 10.1007/s12546-021-09276-y

Triukose, S. et al. Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand. PLoS One 16, e0246274 (2021). DOI: 10.1371/journal.pone.0246274

Rajatanavin, N., Tuangratananon, T., Suphanchaimat, R. & Tangcharoensathien, V. Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Glob Health 6(2021). DOI: 10.1136/bmjgh-2021-006178

Wilasang, C., Jitsuk, N.C., Sararat, C. & Modchang, C. Reconstruction of the transmission dynamics of the first COVID-19 epidemic wave in Thailand. Sci Rep 12, 2002 (2022). DOI: 10.1038/s41598-022-06008-x

Almubark, R.A. et al. Natural History and Clinical Course of Symptomatic and Asymptomatic COVID-19 Patients in the Kingdom of Saudi Arabia. Saudi J Med Med Sci 9, 118-24 (2021). DOI: 10.4103/sjmms.sjmms_853_20

Agodi, A. et al. Gender differences in comorbidities of patients with COVID-19: An Italian local register-based analysis. Heliyon 9, e18109 (2023). DOI: 10.1016/j.heliyon.2023.e18109

Khongsiri, W. et al. Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study. BMC Infect Dis 24, 1116 (2024). DOI: 10.1186/s12879-024-09999-2

Yahav, D. et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect 27, 315-18 (2021). DOI: 10.1016/j.cmi.2020.11.028

Long, Q.X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 26, 1200-204 (2020). DOI: 10.1038/s41591-020-0965-6

Chaimayo, C. et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virol J 17, 177 (2020). DOI: 10.1186/s12985-020-01452-5

Sayabovorn, N. et al. Early diagnosis by antigen test kit and early treatment by antiviral therapy: An ambulatory management strategy during COVID-19 crisis in Thailand. Medicine (Baltimore) 101, e29888 (2022). DOI: 10.1097/MD.0000000000029888

Puenpa, J. et al. Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020-2022. Arch Virol 168, 26 (2023). DOI: 10.1007/s00705-022-05666-6

Puenpa, J. et al. Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing. Viruses 15(2023). DOI: 10.3390/v15061394

Kirca, F. et al. Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron. Rev Assoc Med Bras (1992) 68, 1476-480 (2022). DOI: 10.1590/1806-9282.20220880

Wei, Y.Y. et al. Differential Characteristics of Patients for Hospitalized Severe COVID-19 Infected by the Omicron Variants and Wild Type of SARS-CoV-2 in China. J Inflamm Res 16, 3063-78 (2023). DOI: 10.2147/JIR.S420721

Sandar, U.E., Laohasiriwong, W. & Sornlorm, K. Spatial autocorrelation and heterogenicity of demographic and healthcare factors in the five waves of COVID-19 epidemic in Thailand. Geospat Health 18(2023). DOI: 10.4081/gh.2023.1183

Torjesen, I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ 375, n2943 (2021). DOI: 10.1136/bmj.n2943

Smith, D.M. et al. Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19. JAMA Netw Open 5, e2238867 (2022). DOI: 10.1001/jamanetworkopen.2022.38867

Buskermolen, M. et al. Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: Viral reactivation or inflammatory rebound? J Infect 83, e6-e8 (2021). DOI: 10.1016/j.jinf.2021.06.015

Deng, L. et al. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Sci Rep 12, 20763 (2022). DOI: 10.1038/s41598-022-24220-7

Ukwishaka, J., Ndayishimiye, Y., Destine, E., Danwang, C. & Kirakoya-Samadoulougou, F. Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis. BMC Public Health 23, 778 (2023). DOI: 10.1186/s12889-023-15626-7

Penetra, S.L.S. et al. SARS-CoV-2 reinfection cases in a household-based prospective cohort in Rio de Janeiro. J Infect Dis (2023). DOI: 10.1093/infdis/jiad336

Ye, C. et al. The Omicron Variant Reinfection Risk among Individuals with a Previous SARS-CoV-2 Infection within One Year in Shanghai, China: A Cross-Sectional Study. Vaccines (Basel) 11(2023). DOI: 10.3390/vaccines11071146

Dutta, S. et al. Household Transmission of COVID-19: A Cross-Sectional Study. Infect Drug Resist 13, 4637-642 (2020). DOI: 10.2147/IDR.S285446

Li, F. et al. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis 21, 617-28 (2021). DOI: 10.1016/S1473-3099(20)30981-6

Sordo, A.A. et al. Household transmission of COVID-19 in 2020 in New South Wales, Australia. Commun Dis Intell (2018) 46(2022). DOI: 10.33321/cdi.2022.46.16

Farsalinos, K. et al. Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Ther Adv Chronic Dis 11, 2040622320935765 (2020). DOI: 10.1177/2040622320935765

Lippi, G. & Henry, B.M. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med 75, 107-8 (2020). DOI: 10.1016/j.ejim.2020.03.014

Luu, M.N. et al. Evaluation of risk factors associated with SARS-CoV-2 transmission. Curr Med Res Opin 38, 2021-28 (2022). DOI: 10.1080/03007995.2022.2125258

Paleiron, N. et al. Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study. Nicotine Tob Res 23, 1398-404 (2021). DOI: 10.1093/ntr/ntab004

Patanavanich, R. & Glantz, S.A. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res 22, 1653-56 (2020). DOI: 10.1093/ntr/ntaa082

Phulkerd, S. et al. Life Satisfaction Before and During COVID-19 Pandemic in Thailand.Int J Public Health 68, 1605483 (2023). DOI: 10.3389/ijph.2023.1605483

Downloads

Published

2025-08-30

Issue

Vol. 55 No. 2 (2025): Vol. 55 No. 2 (May-Aug 2025)

Section

Original Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License CC-BY-ND